Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health is offering P30 Cancer Center Support Grants to NCI-Designated Cancer Centers to integrate institutional research capabilities into a single transdisciplinary enterprise. These grants support three distinct center types: Comprehensive Cancer Centers, which bridge basic laboratory, clinical, and population-based research; Clinical Cancer Centers, which focus on a combination of these areas; and Basic Cancer Centers, which specialize in laboratory research. The primary objective of these centers is to drive discoveries regarding the nature of cancer and develop improved methods for prevention, diagnosis, and therapy. Recipients are expected to develop shared resources, collaborate with other NCI-funded programs, and disseminate their findings to benefit the broader community. This opportunity is managed by the Office of Cancer Centers within the National Cancer Institute.

General Info

Funding supports NCI-Designated Cancer Centers to advance interdisciplinary cancer research and collaboration.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

813212 - Voluntary Health Organizations

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health
Office AddressUSA
Contacts
Office of Cancer Centers National Cancer Institute (NCI
contact@example.gov
+1 (555) 000-0000

Full Description

Show more

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Clinical Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas, and 3) Basic Cancer Centers, which focus on basic laboratory research. The purpose of all types of NCI-Designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through this NOFO are expected to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of Shared Resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community.

Similar Contracts

Same NAICS industry code

NAICS: 813212
SLED
Environment and Climate One - FY28 CALL FOR EXPRESSIONS OF INTERESTStop
Solicitation # BD-27-1042-ENV-ENV01-133166
ENV - Executive Office Groups

POSTED

22 days ago

DEADLINE

in 15 days
View Details
NAICS: 813212
SLED
FY2027 DCR Watershed System Salt Reduction Grant
Solicitation # BD-27-1020-DCRCU-DC250-133000
The FY2027 DCR Watershed System Salt Reduction Grant, solicitation number BD-27-1020-DCRCU-DC250-133000, is a matching grant program administered by the Massachusetts Department of Conservation and Recreation, Division of Water Supply Protection. The program provides financial assistance to 18 eligible municipalities within the Wachusett Reservoir, Quabbin Reservoir, and Ware River watershed boundaries that maintain more than ten miles of town roads. The primary objective is to reduce the environmental impact of road salt on drinking water and infrastructure by funding the purchase of efficient salt use reduction technology and equipment, such as pavement temperature sensors, calibrated or automated salt application equipment, flexible plow blades, and salt pile containment materials. Eligible equipment must be tangible personal property with a useful life of at least five years and a per-unit cost of $1,000 or more. The program offers a total funding pool of up to $100,000, with individual community awards capped at $20,000. These are matching grants requiring a 50 percent match from the applicant. Proposals are evaluated on a competitive basis, and the period of performance ends on June 30, 2027. Applicants must submit their proposals electronically via the COMMBUYS portal by October 2, 2026. To receive final reimbursement, grantees must provide baseline salt application data from previous winters, agree to provide impact data for future seasons, and submit a Final Report and Grant Close-Out Form. Payments are issued via Electronic Funds Transfer typically 45 days from invoice receipt, and all awards are subject to the availability of funds through the Water Supply Protection Trust.
DCRCU - DCR CONTRACTS UNIT

POSTED

29 days ago

DEADLINE

in 2 days
View Details
NAICS: 813212
SLED
G-JFS-OWD-Univ-of-Michigan-IRIS
Solicitation # CTR040730
The G-JFS-OWD-Univ-of-Michigan-IRIS solicitation, identified by number CTR040730, is a subsidies contract issued by the Ohio Job and Family Services agency. This SLED organization opportunity is focused on performance within the state of Ohio and is managed by Washington Armondo. The solicitation was officially posted on August 3, 2026, and maintains a response deadline of June 30, 2027. Further details and management of the contract can be accessed through the OhioBuys public portal.
Job And Family Services

POSTED

about 2 months ago

DEADLINE

in 9 months
View Details
NAICS: 813212
Grant
Drug-Free Communities (DFC) Support Program – Competing Continuation (Year 6)The Drug-Free Communities (DFC) Support Program, administered by the Department of Health and Human Services and the Centers for Disease Control and Prevention, is seeking applications for Fiscal Year 2026 grants. This program aims to establish and strengthen collaborations between community coalitions, government entities, and non-profit agencies to prevent and reduce substance use among youth aged 18 and younger. The long-term objective is to decrease substance use among both youth and adults by addressing community risk factors and promoting protective factors. This specific funding opportunity is designated as a competing continuation for Year 6, targeting applicants who have either completed their initial five-year funding cycle or have experienced a lapse in funding. The forecast was posted on July 28, 2026, under NAICS code 813212. Interested parties can contact Christi Jones via email at dfc_nofo@cdc.gov for further information.
Centers For Disease Control - Ncipc

POSTED

2 months ago

DEADLINE

N/A
View Details
NAICS: 813212
Grant
National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and ProvidersThe National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers initiative by the CDC aims to reduce morbidity and mortality associated with hepatitis B and C. The program focuses on increasing awareness of prevention, testing, and treatment options among disproportionately affected populations while enhancing the competence of healthcare professionals in evaluating and treating these infections. The opportunity is divided into two distinct components. Part A focuses on community education and capacity building by managing coalitions of public and private organizations, providing technical assistance for outreach, and improving testing and linkage to treatment. Part B centers on professional education by providing free, web-based, on-demand training and resources for healthcare professionals, including continuing education credits. Organizations may apply for one or both components via separate applications.
Centers For Disease Control - Nchhstp

POSTED

3 months ago

DEADLINE

N/A
View Details
NAICS: 813212
Grant
2026 Alaska Marine Education and Training Mini-Grant Program
Solicitation # NOAA-NMFS-AK-2026-33268
The 2026 Alaska Marine Education and Training Mini-Grant Program, solicitation number NOAA-NMFS-AK-2026-33268, is a funding opportunity issued by the National Oceanic and Atmospheric Administration to support projects that enhance the sustainability and competitiveness of Alaska's marine community. In alignment with Executive Order 14276, the program prioritizes workforce development for marine-related professions, including marine science, aquaculture, and maritime operations. Key focus areas include improving seafood safety and marketing, implementing technological innovations in fishing practices, and utilizing local knowledge for regionally-specific fishery management. All proposed projects must be conducted within Alaska. Applicants must be registered in SAM.gov, eRA Commons, and Grants.gov, and provide a Unique Entity Identifier. The application process requires specific federal forms, including SF-424, SF-424A, SF-424B, and CD-511, along with a project narrative, a title page and abstract, and a NEPA questionnaire. Proposals are evaluated based on technical and scientific merit, applicant qualifications, outreach and education strategies, and the realism of project costs. Awards are generally granted based on rank order of average reviewer scores, though the Selecting Official may adjust selections based on funding availability, geographic distribution, and program priorities. The period of performance for these grants begins no earlier than September 1, 2026, with subsequent cycles starting in 2027 and 2028. Recipients are required to submit financial and technical performance reports semi-annually via eRA. Additionally, the program mandates strict adherence to science integrity standards and the NOAA Sexual Assault and Sexual Harassment Prevention and Response Policy to ensure a safe and professional research environment. Submission deadlines are set for June 22, 2026, May 3, 2027, and May 1, 2028.
Department Of Commerce Noaa

POSTED

5 months ago

DEADLINE

in over 1 year
View Details
NAICS: 813212
Grant
Preventing Youth Overdose: Treatment, Recovery, Education, Awareness and TrainingThis contract focuses on a program aimed at preventing youth overdose by enhancing local awareness of fentanyl risks among young people. It seeks to broaden screening and diagnosis efforts for opioid use disorder (OUD) in youth populations and improve access to medications for opioid use disorder (MOUD). The initiative also aims to provide comprehensive training for healthcare providers, families, and school personnel on effective strategies to support youth affected by OUD and those undergoing MOUD treatment. The program is administered by the Substance Abuse and Mental Health Services Administration under the Department of Health and Human Services and was posted on March 20, 2026. It includes outreach, education, treatment, recovery, and training components designed to address the opioid crisis among youth comprehensively. Contact for the program is available via Arianna Douglas, with communication details provided. The project supports multi-sector collaboration to reduce overdose risk and enhance the overall health and safety of youth communities.
Substance Abuse And Mental Health Services Adminis

POSTED

6 months ago

DEADLINE

N/A
View Details
NAICS: 813212
SLED
Grant a conditional waiver of fees in the amount of $69,000 for three in-lieu parking certificates for the property located at 224 and 226 Ocean Avenue in consi
Solicitation # NOE 224
The City of Laguna Beach has granted a conditional waiver of fees totaling 69,000 dollars for three in-lieu parking certificates associated with the properties located at 224 and 226 Ocean Avenue. This action is intended to provide a public benefit by stimulating business development, expanding employment opportunities, and increasing the city tax base. The waiver is strictly contingent upon the property owner obtaining an effective coastal development permit for the three parking certificates. The project is classified as a special notice under solicitation NOE 224 and is managed by Senior Management Analyst Louie Lacasella. It has been determined that the action is exempt from the California Environmental Quality Act under the existing facilities exemption of 14 CCR Section 15301 and the commonsense exemption of 14 CCR Section 15061(b)(3), as the issuance of these certificates will not result in any physical changes to the properties.
City of Laguna Beach

POSTED

11 months ago

DEADLINE

N/A
View Details
NAICS: 813212
Grant
Engaging faith-based organizations to sustain lifesaving HIV and TB services in EthiopiaThe Centers for Disease Control and Department of Health and Human Services are seeking to engage faith-based organizations to support and sustain critical HIV, TB, and cervical cancer services in Ethiopia. The initiative focuses on providing HIV testing, prevention, and adult and pediatric care and treatment, specifically targeting high-risk individuals, undiagnosed persons, those at risk of interrupting treatment, and pregnant or breastfeeding women. The goal is to implement cost-efficient models integrated with routine healthcare delivery to reach populations facing barriers to conventional health services. The project emphasizes country ownership and sustainability through country-led plans and may include activities addressing other public health threats and emergencies in Ethiopia. While the award ceiling for the first year is listed as zero, the CDC anticipates an approximate total funding amount of 5,000,000 dollars for Year 1, depending on the availability of funds.
Centers For Disease Control-Ghc

POSTED

12 months ago

DEADLINE

N/A
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

New
Grant
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 513130
New
Grant
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.
Book Publishers

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

9 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Emerging Global Leader Award (K43)The Emerging Global Leader Award (K43), issued by the National Institutes of Health under the Department of Health and Human Services, provides salary and research support to junior faculty and research scientists based at academic or research institutions in Low- and Middle-Income Countries. The program focuses on biomedical, behavioral, and clinical research that leverages unique opportunities in these regions to create generalizable knowledge benefiting both U.S. and international populations. Recipients must engage in intensive mentored research and career development guided by senior researchers from both the U.S. and their respective home countries. By leveraging existing NIH research investments, the initiative aims to develop global research leaders who can mentor future investigators and strengthen international research networks.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

15 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS